Commercial Aquaculture Vaccines Market Growth Factors, Opportunities, Ongoing Trends and Key Players 2032

Increasing risk of transmission of pathogens from animal food is expected surge demand for commercial aquaculture vaccines. According to the Food and Agriculture Organization (FAO) of the United Nations 2020, aquaculture accounted for around 46 percent of total food production and 52 percent of fish for human consumption. Besides, aquatic species farming is one of the fastest-growing food sectors, globally. Commercial aquaculture vaccines are projected to gain traction due to shift of the aquaculture industry toward preventive vaccinations from conventional antibiotic treatments, due to increased risk of dissemination. According to the Global Aquaculture Alliance, Chilean salmon farmers have cut antibiotic usage substantially over the last three years.

Request For Free Sample Report of "Commercial Aquaculture Vaccines Market"@ https://www.persistencemarketresearch.com/samples/32289

An increase in global consumption and production of aquatic species exhibits exponential growth potential for the commercial aquaculture vaccines market. Additionally, increased prevalence of bacterial and zoonotic infections among aquaculture species has been observed, which has widened market opportunities.

The COVID-19 pandemic has changed animal healthcare priorities and spending, but this is considered to be a short-term negative impact on the vaccines market. Disruptions in supply chain across the global fish aquaculture industry and rising awareness of animal to human pathogen transmission risks are expected to slow down the market in the short term.

Overall, the global commercial aquaculture vaccines market is projected to expand at a healthy CAGR of close to 7% through 2030.

Key Takeaways from Commercial Aquaculture Vaccines Market Study          

Based on vaccine type, inactivated vaccines are the most profitable segment leading the market, and are expected to gain more than 70% of market revenue share over the forecast period.
Among all the pathogens, bacteria widely dominates (over 70%) due to high prevalence of bacterial infections among aquaculture.
Salmon is a widely dominating species in the market, due to rising production of the fish in leading developed countries, accounting for more than 55% of market share value.
The intraperitoneal route of administration is most preferred, due to high immune response elicitation of fish, and low stress and post-vaccination side effects.
Among the different end-users, fish farming companies will hold more than 80% of revenue share over the forecast period.
Europe is the largest market for commercial aquaculture vaccines, with Norway holding close to half of the share in this regional market.
Growth of the market is pegged at just 2.2% in 2021, but over the long term through 2030, it will get back to its normal growth trajectory of close to 7% CAGR.

"Increasing awareness of animal food pathogen transmission risks and rising prevalence of zoonotic infections are expected to boost demand for commercial aquaculture vaccines market," says an analyst of Persistence Market Research

Companies

Pfizer, Inc.
Boehringer Ingelheim International GmbH
Janssen Pharmaceuticals, Inc.
Sanofi SAIS
Sun Pharmaceutical Industries Ltd.
Actavis Plc. [Teva

Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/32289

Trends in Commercial Aquaculture Vaccines Market

The manual vaccination process led to various adverse effects with high costs, owing to the lack of highly skilled and large number workforce needed, significant handling stress, and risk of post-vaccination infections. Thus, increased shift toward automated vaccination technology is expected to boost the commercial aquaculture vaccines market growth. For instance, Aqualife developed an automated Incubot 2, a mobile platform that would offer automated vaccination to smaller fish farms.

Rising demand for insurance in matured markets is an upcoming trend. Favourable insurance policies is an emerging trend to sustain the commercial aquaculture vaccines market across the globe. Introduction of third-party payers has supported the aquaculture sector globally, leading to a build-up of new sales channels for aquaculture vaccines.

For instance, according to the Food and Agriculture Organization of U. N., around 83 percent of fishers purchase insurance coverage for fish aquaculture farming.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the Commercial Aquaculture Vaccines market in its latest study, presenting historical demand assessment of 2016 - 2020 and projections for 2021 - 2031. The research study is based on product (morphine, codeine, fentanyl, meperidine, and methadone), application (analgesia, cough suppression, and diarrhoea suppression), and distribution channel (hospital pharmacies, retail pharmacies, drug stores, clinics, and others), across seven key regions of the world.

Request Customization @ https://www.persistencemarketresearch.com/request-customization/32289

 Key Questions Answered in This Report.

What are the Roadblocks for Commercial Aquaculture Vaccines Suppliers?
What are the Key Opportunities for Commercial Aquaculture Vaccines Manufacturers?
How is Focus on Safety Influencing Commercial Aquaculture Vaccines Demand?
What is the Regulatory Impact on Global Sales of Commercial Aquaculture Vaccines?
Which Region Offers the Largest Opportunity for Sales of Commercial Aquaculture Vaccines?
Where Does the U.S. Stand in the Market for Commercial Aquaculture Vaccines?
What Is the Outlook for Commercial Aquaculture Vaccines Manufacturers in China?
Why is Germany a Lucrative Market for Commercial Aquaculture Vaccines Manufacturers?
Why Will Belgium Outpace Other European Markets for Commercial Aquaculture Vaccines?
Why is There High Demand for Tires in Commercial Aquaculture Vaccines?
Why are Sales of Commercial Aquaculture Vaccines Surging?

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.